Skip to content
Catalyst

(R)-carnitineFinding

(R)-carnitine decreases aspartate aminotransferase

lowersVery limited evidenceFindingreplicated ×2

01 · The sentence it was drawn from

“Random effects model meta-analysis showed that carnitine supplementation led to reduction in serum ALT (weighted mean difference [WMD] - 10.25 IU/L; 95% CI = - 15.73, - 4.77; p < 0.001) and AST levels (WMD - 7.85 IU/L; 95% CI = - 11.85, - 3.86; p < 0.001).”
Quoted verbatim from Effects of carnitine supplementation on liver aminotransferase enzymes: A systematic review and meta-analysis of randomized controlled clinical trials.
This finding among the 50 findings on its endpoint

(R)-carnitine

Aspartate aminotransferase

lowers

Effect as reported

−7.85mean difference

CI −11.85 to −3.86

Who
Participants of 17 randomized controlled trials, pooled analysis
Dose studied
not reported

Very limited evidencePMID 31828538 · 2019

02 · The study

Study
meta-analysis
Duration
not reported

Evidence, by strength

  • strong
  • moderate
  • limited
  • very limitedthis finding
  • insufficient

03 · The paper

Indian journal of gastroenterology
What else it reported2 findings · 1 compound · 2 endpoints

04 · To cite this finding

This address does not change

https://catalystproject.ai/e/01M701ECKT0YQEFFA57E0E1NJR